Vitiligo, a common depigmenting skin disorder, has an estimated prevalence of 0.5–2% of
the population worldwide. The disease is characterized by the selective loss of melanocytes …

The aetiopathogenic mechanisms of vitiligo are still poorly understood, and this has held
back progress in diagnosis and treatment. Up until now, treatment guidelines have existed at …

British Association of Dermatologists guidelines for the management of people with vitiligo 2021*
| British Journal of Dermatology | Oxford Academic Skip to Main Content Advertisement intended …

Vitiligo is a common skin disorder that results in depigmentation. With the appropriate
management, many patients can minimize disease progression, attain repigmentation, and …

Background. Vitiligo is an acquired depigmenting disease with uncertain aetiopathogenesis,
possibly associated with oxidative stress. Narrowband ultraviolet B phototherapy (NB‐UVB) …

Background The pathogenesis of vitiligo remains a topic of extensive debate. This is partly
due to the moderate efficacy of current treatments. The role of the oxidative stress pathway in …

Vitiligo is an acquired depigmenting disorder characterized by the loss of functioning
epidermal melanocytes because of multifactorial and overlapping pathogenetic …

Vitiligo is a chronic skin disorder characterised by the loss of melanocytes and subsequent
skin depigmentation. Although many theories have been proposed in the literature, none …

Vitiligo is an acquired dermatological disease frequently associated with autoimmune
thyroid disorders. Several theories have been proposed so far to unravel the complex vitiligo …

Background While a plethora of literature continues to be published on the role of nutritional
agents both in lay press and indexed journals, the data is not on a firm footing and leaves …